Richard A. Gonzalez
Chairman of the Board and Chief Executive Officer

Rick Gonzalez is Chairman of the Board and Chief Executive Officer of AbbVie, a global biopharmaceutical company employing approximately ~30,000 people and marketing medicines in more than 175 countries. Prior to AbbVie’s separation from Abbott, Mr. Gonzalez was a 30-year Abbott veteran. He served as Executive Vice President, Pharmaceutical Products Group, where he led the global pharmaceutical business, including commercial operations, research and development and manufacturing. He also served as President and Chief Operating Officer, prior to a brief retirement.

Laura J. Schumacher
Executive Vice President, External Affairs, General Counsel and Corporate Secretary

Laura Schumacher is Executive Vice President, External Affairs, General Counsel and Corporate Secretary, responsible for AbbVie’s externally facing functions of Health Economics Outcomes Research, Government Affairs, Corporate Responsibility, Brand and Communications. She also leads all legal functions. Prior to AbbVie’s separation from Abbott, Ms. Schumacher served as Executive Vice President, General Counsel and Secretary, where she also had responsibility for the Office of Ethics and Compliance. Both at Abbott and AbbVie, Ms. Schumacher has led Licensing & Acquisitions and Ventures and Early Stage Collaborations. She serves on the board of General Dynamics.

William J. Chase
Executive Vice President, Finance and Administration

Bill Chase is Executive Vice President, Finance and Administration. He previously served as Executive Vice President, Chief Financial Officer. Prior to AbbVie’s separation from Abbott, Mr. Chase served as Vice President, Licensing and Acquisitions. He has also served as Vice President and Treasurer, Divisional Vice President and Controller for the global pharmaceutical business.

Carlos Alban
Executive Vice President, Commercial Operations

Carlos Alban is Executive Vice President, Commercial Operations. Prior to AbbVie’s separation from Abbott, Mr. Alban served as Senior Vice President, Proprietary Pharmaceutical Products, Global Commercial Operations. He held a number of management positions in the international pharmaceutical business.

Michael E. Severino, M.D.
Executive Vice President, Research & Development and Chief Scientific Officer

Dr. Severino is the Executive Vice President, Research & Development, and Chief Scientific Officer of AbbVie. He previously served as Senior Vice President, Global Development and Corporate Chief Medical Officer at Amgen Inc. Dr. Severino held other management roles at Amgen, Inc., including Vice President, Global Development and Vice President, Therapeutic Area Head, General Medicine and Inflammation Global Clinical Development. He joined AbbVie in 2014.

Henry O. Gosebruch
Executive Vice President and Chief Strategy Officer

Mr. Gosebruch is Executive Vice President and Chief Strategy Officer. Prior to joining AbbVie in 2015, Mr. Gosebruch worked for more than 20 years in the Mergers & Acquisitions Group at J.P. Morgan Securities LLC, most recently as Co-Head of M&A North America.

Timothy J. Richmond
Executive Vice President, Chief Human Resources​ Officer

Tim Richmond is Executive Vice President, Chief Human Resources Officer.  Prior to AbbVie's separation from Abbott, Mr. Richmond served as Divisional Vice President, Compensation and Benefits. He previously held various HR management positions with 3M Company.

Azita Saleki-Gerhardt, Ph.D.
Executive Vice President, Operations

Azita Saleki-Gerhardt is Executive Vice President, Operations. Prior to AbbVie’s separation from Abbott, Dr. Saleki-Gerhardt was Vice President, Pharmaceuticals, Manufacturing and Supply.

Robert A. Michael
Senior Vice President, Chief Financial Officer

Mr. Michael is Senior Vice President, Chief Financial Officer. Previously Mr. Michael was Vice President, Controller. Prior to AbbVie’s separation from Abbott, he held numerous positions in the finance organization.

Karen Hale
Vice President, Chief Ethics and Compliance Officer

Karen Hale is Vice President, Chief Ethics and Compliance Officer. Prior to her current role, Ms. Hale was Vice President and Associate General Counsel, Litigation & Legal Specialty Operations.

Wulff-Erik Von Borcke
President, Pharmacyclics

Wulff-Erik von Borcke is President of Pharmacyclics, a wholly owned subsidiary of AbbVie that operates from its Sunnyvale, California, headquarters. Mr. von Borcke held a number of leadership positions within Abbott and AbbVie’s global pharmaceutical business, including his most recent role as Vice President, Global Marketing, where he led the global marketing of AbbVie products across all therapeutic areas.

Learn more about our corporate governance structure.

Our culture of innovation and responsibility starts with our board of directors and extends out to every member of the company. Our board members work closely with AbbVie leaders to maintain our focus of putting patients first.

Richard A. Gonzalez

Chairman of the Board and Chief Executive Officer
AbbVie Inc.
North Chicago, Illinois

Robert J. Alpern, M.D.

Ensign Professor of Medicine,
Professor of Internal Medicine, and Dean
Yale School of Medicine
New Haven, Connecticut

Roxanne S. Austin

President
Austin Investment Advisors
Newport Coast, California

William H.L. Burnside

Retired Senior Vice President and Director
The Boston Consulting Group
Los Angeles, California

Brett J. Hart

Executive Vice President, Chief Administrative Officer and General Counsel
United Continental Holdings, Inc.
Chicago, Illinois

Edward M. Liddy

Retired Chairman and CEO
The Allstate Company
Chicago, Illinois

Melody B. Meyer

President
Melody Meyer Energy, LLC
Houston, Texas

Edward J. Rapp

Retired Group President for Resource Industries
Caterpillar Inc.
Peoria, Illinois

Rebecca B. Roberts

Retired President
Chevron Pipe Line Company
Houston, Texas

Glenn F. Tilton

Retired Chairman and Chief Executive Officer
UAL Corporation
Chicago, Illinois

Frederick H. Waddell

Chairman of the Board and Retired Chief Executive Officer
Northern Trust Corporation and The Northern Trust Company
Chicago, Illinois

Audit Committee

Roxanne Austin, chair
William Burnside
Melody Meyer
Edward Rapp
Frederick Waddell

Compensation Committee

Edward Liddy, chair
Roxanne Austin
Glenn Tilton
Frederick Waddell

Nominations and Governance Committee

Glenn Tilton, chair
Robert Alpern
William Burnside
Brett Hart
Rebecca Roberts

Executive Committee

Richard Gonzalez, chair
Roxanne Austin
Edward Liddy
Edward Rapp
Glenn Tilton

Public Policy Committee

Edward Rapp, chair
Robert Alpern
Brett Hart
Edward Liddy
Melody Meyer
Rebecca Roberts